Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
19.65
-0.41 (-2.07%)
At close: Jul 1, 2025, 4:00 PM
19.65
0.00 (0.03%)
After-hours: Jul 1, 2025, 4:00 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.16 billion as of July 1, 2025. Its market cap has increased by 8.32% in one year.
Market Cap
1.16B
Enterprise Value
870.27M
1-Year Change
8.32%
Ranking
Category
Stock Price
$19.65
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.16B, an increase of 19.01%. That is a compound annual growth rate of 7.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 1.18B | 7.64% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.01B |
| Johnson & Johnson | 374.26B |
| AbbVie | 334.57B |
| Novo Nordisk | 307.21B |
| UnitedHealth Group | 292.88B |
| Novartis AG | 236.92B |
| Abbott Laboratories | 236.67B |
| AstraZeneca | 221.10B |